We are live on ! Find out more
BTAL icon

AGF US Market Neutral Anti-Beta Fund
BTAL

5 hedge funds and large institutions have $748K invested in AGF US Market Neutral Anti-Beta Fund in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

57.54% less ownership

Funds ownership: 76.69% → 19.16% (-58%)

93% less capital invested

Capital invested by funds: $11.2M → $748K (-$10.5M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$24.8K
2
TRCT
Tower Research Capital (TRC)
New York
+$4.02K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$9.13M
2
LPT
Legacy Private Trust
Wisconsin
-$1.59M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$63K
4
WA
WFG Advisors
Texas
-$6K
5
Citigroup
Citigroup
New York
-$2.81K

BTAL Hedge Fund Activity: Q3 2013 in Review

5 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in AGF US Market Neutral Anti-Beta Fund (BTAL) for Q3 2013, worth a combined $748K — down 93% from $11.2M a quarter earlier.

Fund positioning in BTAL was balanced in Q3 2013: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 2 trimmed.

The largest buyer was UBS, opening a new position worth an estimated $24.8K. The largest seller was Deutsche Bank, cutting an estimated $9.13M.

  • 5 institutional investors held AGF US Market Neutral Anti-Beta Fund (BTAL) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $748K of AGF US Market Neutral Anti-Beta Fund stock for Q3 2013, down 93% quarter-over-quarter.
  • 3 funds opened new AGF US Market Neutral Anti-Beta Fund positions in Q3 2013 and 3 closed out, a net change of 0 holders.
  • The largest AGF US Market Neutral Anti-Beta Fund buyer in Q3 2013 was UBS, an estimated $24.8K added.
  • The largest AGF US Market Neutral Anti-Beta Fund seller in Q3 2013 was Deutsche Bank, an estimated $9.13M sold.

Based on aggregated 13F filings for Q3 2013.